Your browser doesn't support javascript.
loading
Artificial intelligence to improve cytology performance in urothelial carcinoma diagnosis: results from validation phase of the French, multicenter, prospective VISIOCYT1 trial.
Lebret, Thierry; Paoletti, Xavier; Pignot, Geraldine; Roumiguié, Mathieu; Colombel, Marc; Savareux, Laurent; Verhoest, Grégory; Guy, Laurent; Rigaud, Jérome; De Vergie, Stéphane; Poinas, Grégoire; Droupy, Stéphane; Kleinclauss, François; Courtade-Saïdi, Monique; Piaton, Eric; Radulescu, Camelia; Rioux-Leclercq, Nathalie; Kandel-Aznar, Christine; Renaudin, Karine; Cochand-Priollet, Béatrix; Allory, Yves; Nivet, Sébastien; Rouprêt, Morgan.
Afiliación
  • Lebret T; Urology Department, Foch Hospital, Suresnes, France.
  • Paoletti X; Institut Curie, Saint Cloud, France.
  • Pignot G; Université Versailles Saint-Quentin, Université Paris-Saclay, Saint Cloud, France.
  • Roumiguié M; Urology Department, Institut Paoli-Calmettes, Marseille, France.
  • Colombel M; Urology Department, Centre Hospitalier Universitaire (CHU) Rangueil, IUCT Oncopole, Toulouse, France.
  • Savareux L; Urology Department, Hôpital Edouard Herriot, Lyon, France.
  • Verhoest G; Urology Auvergne Centre, Clinique de la Chataigneraie, Beaumont, France.
  • Guy L; Urology Department, CHU Pontchaillou, Rennes, France.
  • Rigaud J; Urology Department of Urology, CHU Gabriel Montpied, Clermont-Ferrand, France.
  • De Vergie S; Urology Department, CHU Hôtel-Dieu, Nantes, France.
  • Poinas G; Urology Department, CHU Hôtel-Dieu, Nantes, France.
  • Droupy S; Urology Department, Clinique Beausoleil, Montpellier, France.
  • Kleinclauss F; Urology Department, CHU Caremeau, Nîmes, France.
  • Courtade-Saïdi M; Urology Department, CHU Besançon, Besançon, France.
  • Piaton E; Pathology and Cytology Department, CHU Toulouse, IUCT Oncopole, Toulouse, France.
  • Radulescu C; Centre de Pathologie Est, Hospices Civils de Lyon, Hôpital Femme-Mère-Enfant, Bron, France.
  • Rioux-Leclercq N; Service d'Anatomie et Cytologie Pathologiques, Hôpital Foch, Suresnes, France.
  • Kandel-Aznar C; Department of Pathology, CHU Pontchaillou, Rennes, France.
  • Renaudin K; Laboratoire d'Anatomie et Cytologie Pathologique, CHU Hôtel Dieu, Nantes, France.
  • Cochand-Priollet B; Department of Pathology, CHU Hôtel Dieu, Nantes, France.
  • Allory Y; Centre de Recherche en Transplantation et en Immunologie, UMR 1064, INSERM, Université de Nantes, Nantes, France.
  • Nivet S; Department of Pathology, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Rouprêt M; Department of Pathology, Institut Curie, Saint-Cloud, France.
World J Urol ; 41(9): 2381-2388, 2023 Sep.
Article en En | MEDLINE | ID: mdl-37480491
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias de la Vejiga Urinaria / Carcinoma de Células Transicionales Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies Límite: Adult / Humans Idioma: En Revista: World J Urol Año: 2023 Tipo del documento: Article País de afiliación: Francia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias de la Vejiga Urinaria / Carcinoma de Células Transicionales Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies Límite: Adult / Humans Idioma: En Revista: World J Urol Año: 2023 Tipo del documento: Article País de afiliación: Francia